C. Haie-Méder

Radiotherapy of cervical cancer.

Cyrus Chargari, C. Durdux, A. Escande, 2021, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Radiotherapy for endometrial cancer.

Cyrus Chargari, C. Durdux, A. Escande, 2021, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Endometrial disorders in patients with peritoneal serous papillary carcinoma.

P. Morice, P. Duvillard, P. Pautier, 2007, European journal of obstetrics, gynecology, and reproductive biology.

Role of radiotherapy in the management of vulvar cancer: Recommendations of the French society for radiation oncology.

D. Peiffert, C. Durdux, A. Escande, 2021, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer

H. Putter, C. Haie-meder, D. Katsaros, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Radiotherapy for penile cancers

Cyrus Chargari, D. Peiffert, A. Escande, 2021, Cancer/Radiothérapie.

Role of radiotherapy in the treatment of primary vaginal cancer: Recommendations of the French society for radiation oncology

Cyrus Chargari, D. Peiffert, C. Durdux, 2021, Cancer/Radiothérapie.

OC-0369: Long-Term Quality of Life after (chemo)radiotherapy for high-risk Endometrial Cancer in PORTEC-3

H. Putter, D. Katsaros, J. Ledermann, 2020 .

Radiotherapy Quality Assurance in the PORTEC-3 (TROG 08.04) Trial

A. Fyles, M. Bailey, V. Do, 2021, Clinical Oncology.

397 Molecular profiling of NSMP high-risk endometrial cancers of the PORTEC-3 trial – prognostic refinement and druggable targets

A. Leary, N. Horeweg, P. Bessette, 2021, Endometrial cancer.